Pharmaceutical Benefits Scheme Drug Listings

Follow the links below to find information about the listing of drugs on the Pharmaceutical Benefits Scheme (PBS).

Reviewed February 2009

Printer friendly page

19 Resources Found
Results 1 to 19 displayed.
Title:   PBS
Publisher:   Australian Government Department of Health and Ageing
Description:   This web site contains the Schedule of Pharmaceutical Benefits, a listing of the medicines subsidised by the Australian Government.
Date:   Feb 2010
Title:   Media release. New listings and changes to PBS from 1 August 2009
Publisher:   Australian Government Department of Health and Ageing
Description:   Several new listings and changes to the Pharmaceutical Benefits Scheme (PBS) from 1 August will bring health benefits to many Australians.
Date:   Aug 2009
Title:   Media release. Government subsidises new drugs
Publisher:   Australian Government Department of Health and Ageing
Description:   The Australian Government will subsidise new forms of several drugs already listed on the PBS and will extend the listing of Adalimumab as an alternative treatment for severe psoriasis from 1 June.
Date:   Jun 2009
Title:   Media release. Government subsidises new drugs on the PBS
Publisher:   Australian Government Department of Health and Ageing
Description:   The Government will subsidise new drugs on the Pharmaceutical Benefits Scheme from 1 May and several other drugs, already listed on the PBS, will become available in new forms.
Date:   May 2009
Title:   Media release. New PBS medicines listed - April 2009
Publisher:   Australian Government Department of Health and Ageing
Description:   Older women with osteoporosis, children with tyrosinemia and people with restless legs syndrome will benefit from the additions and changes to medicines subsidised by the Australian Government on the Pharmaceutical Benefits Scheme from 1 April.
Date:   Apr 2009
Title:   Media release. New government-subsidised medicines: PBS listings
Publisher:   Australian Government Department of Health and Ageing
Description:   As a result of new PBS listings, and new medication strengths, patients with hypertension will benefit from increased treatment options.
Date:   Mar 2009
Title:   Subsidised medicines for Aboriginal and Torres Strait Islander people
Publisher:   Australian Prescriber
Description:   Since August 2006, the Pharmaceutical Benefits Scheme (PBS) has been including new listings specifically for the treatment of common conditions in Aboriginal and Torres Strait Islander people.
Date:   Aug 2008
Title:   New quit smoking drug varenicline (Champix ®) added to PBS
Publisher:  
Description:   Varenicline has been listed under the PBS (Pharmaceutical Benefits Scheme) from January 1 2008.
Date:   Jan 2008
Title:   New listings for the treatment of age-related macular degeneration
Publisher:   Australian Government Department of Health and Ageing
Description:   LUCENTIS® (ranibizumab) is a new drug that will be listed on the Pharmaceutical Benefits Scheme from 1 August 2007 for the treatment of wet age related macular degeneration.
Date:   Jun 2007
Title:   PBAC: taxanes
Publisher:   Australian Prescriber
Description:   The listing of trastuzumab on the Pharmaceutical Benefits Scheme (PBS) in October 2006 was heralded with much fanfare. Along with this listing, changes to the prescribing requirements for taxanes also occurred.
Date:   Feb 2007
Title:   Guidelines for preparing submissions to the Pharmaceutical Benefits Advisory Committee (version 4.0)
Publisher:   Australian Government Department of Health and Ageing
Description:   The Pharmaceutical Benefits Advisory Committee (PBAC) endorsed this edition of its Guidelines in November 2006. It follows an extensive consultation process and provides guidance for all stakeholders involved in or affected by submissions to the PBAC or listings on the Pharmaceutical Benefits Scheme or the National Immunisation Program.
Date:   Dec 2006
Title:   Subsidies for Aricept, Exelon and Reminyl: what are the conditions?
Publisher:   Alzheimer's Australia
Description:   Aricept, Exelon and Reminyl are now approved for listing on the Pharmaceutical Benefits Schedule (PBS) but only for people with mild to moderate Alzheimer's disease and subject to certain conditions. This Update Sheet provides information about the conditions that need to be met in order to receive these medications at the subsidised rate.
Date:   Oct 2006
Title:   Listing of Herceptin on the PBS
Publisher:   Australian Government Department of Health and Ageing
Description:   The Government has accepted a recommendation from the Pharmaceutical Benefits Advisory Committee (PBAC) to list the drug trastuzumab (Herceptin®) on the Pharmaceutical Benefits Scheme (PBS).
Date:   Oct 2006
Title:   Risperidone (Risperdal) for behavioural disturbances in dementia
Publisher:   Australian Prescriber
Description:   Risperidone has been PBS-listed as an authority item for behavioural disturbances characterised by psychotic symptoms and aggression in patients with dementia where non-pharmacological methods have been unsuccessful.
Date:   Jun 2005
Title:   Oral isotretinoin
Publisher:   Australian Prescriber
Description:   Oral isotretinoin is listed on the Australian Pharmaceutical Benefits Scheme for patients with severe cystic acne that has failed to respond adequately to other therapy. A single course of isotretinoin induces a long-term remission in over 80% of these patients.
Date:   Jun 2005
Title:   Underneath the RADAR: moxifloxacin
Publisher:   Australian Prescriber
Description:   The quinolone antibiotic moxifloxacin has been listed on the Pharmaceutical Benefits Scheme (PBS), for the oral treatment of community-acquired pneumonia in adults and children over 12 years old who have immediate hypersensitivity to penicillin. This new listing extends the number of patients who can be treated with moxifloxacin.
Date:   Dec 2003
Title:   EpiPen and EpiPen Jr recommended for PBS listing
Publisher:   Australasian Society of Clinical Immunology and Allergy (ASCIA)
Description:   EpiPen and EpiPen Jr are pre-loaded syringes that inject a single dose of adrenaline for the emergency treatment of adults and children who experience severe and potentially life-threatening allergic reactions (anaphylaxis, or 'allergic shock').
Date:   Aug 2003
Title:   Your questions to the PBAC. Availability of bulking and osmotic laxative agents as pharmaceutical benefits
Publisher:   Australian Prescriber
Description:   The PBAC is reluctant to recommend laxative products for listing on the PBS and considers that other measures such as modification of diet can be used in the treatment of constipation in most patients.
Date:   Apr 2003
Title:   New listing cuts the costs of leukaemia drug - myDr.com.au
Publisher:   myDr
Description:   A broader Pharmaceutical Benefits Scheme listing for Glivec, a once-daily capsule for the treatment of chronic myeloid leukaemia, means more patients can afford the breakthrough treatment.
Date:   Sep 2002
Results 1 to 19 displayed.